{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:48:00Z","timestamp":1774435680893,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["097330\/Z\/11\/Z"],"award-info":[{"award-number":["097330\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13071-017-2566-x","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T20:43:14Z","timestamp":1514407394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-na\u00efve trachoma-endemic island communities in West Africa"],"prefix":"10.1186","volume":"10","author":[{"given":"Anna R.","family":"Last","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Burr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Harding-Esch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice","family":"Cassama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meno","family":"Nabicassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrissy h.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C. W.","family":"Mabey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"2566_CR1","first-page":"844","volume":"82","author":"S Resnikoff","year":"2004","unstructured":"Resnikoff S, Pascolini D, Etya\u2019ale D, Kocur I, Pararajaseguram R, Pokharel GP, Mariotti SP. global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844\u201351.","journal-title":"Bull World Health Organ"},{"issue":"9960","key":"2566_CR2","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(13)62182-0","volume":"384","author":"HR Taylor","year":"2014","unstructured":"Taylor HR, Burton MJ, Haddad D, West S, Wright H. Trachoma. Lancet. 2014;384(9960):2142\u201352.","journal-title":"Lancet"},{"issue":"6","key":"2566_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-3156.2010.02521.x","volume":"15","author":"H VH","year":"2010","unstructured":"VH H, Harding-Esch EM, Burton MJ, Bailey RL, Kadimpeul J, Mabey DC. Epidemiology and control of trachoma: systematic review. Tropical Med Int Health. 2010;15(6):673\u201391.","journal-title":"Tropical Med Int Health"},{"issue":"6","key":"2566_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000462","volume":"3","author":"M Gambhir","year":"2009","unstructured":"Gambhir M, Bas\u00e1\u00f1ez MG, Burton MJ, Solomon AW, Bailey RL, Holland MJ, et al. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis. 2009;3(6):e462.","journal-title":"PLoS Negl Trop Dis"},{"key":"2566_CR5","volume-title":"Guide to trachoma control in programs for the prevention of blindness","author":"CR Dawson","year":"1981","unstructured":"Dawson CR, Jones BR, Tarizzo ML. Guide to trachoma control in programs for the prevention of blindness. Geneva: World Health Organization; 1981."},{"key":"2566_CR6","unstructured":"World Health Organization (WHO). Report of the third global scientific meeting on trachoma elimination. Geneva: World Health Organization; 2010."},{"key":"2566_CR7","volume-title":"Trachoma Control: A Guide for Programme Managers","author":"WHO","year":"2006","unstructured":"WHO. Trachoma Control: A Guide for Programme Managers. Geneva: World Health Organization; 2006."},{"key":"2566_CR8","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMoa040979","volume":"351","author":"AW Solomon","year":"2004","unstructured":"Solomon AW, Holland MJ, Alexander ND, Massae P, Aguirre A, Natividad-Sancho A, et al. Mass treatment with single dose azithromycin for trachoma. N Engl J Med. 2004;351:1962\u201371.","journal-title":"N Engl J Med"},{"issue":"5","key":"2566_CR9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/8451","volume":"5","author":"T Lietman","year":"1999","unstructured":"Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nature Med. 1999;5(5):572\u20136.","journal-title":"Nature Med"},{"key":"2566_CR10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/infdis\/jir257","volume":"204","author":"SK West","year":"2011","unstructured":"West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyperendemic communities in Tanzania. J Infect Dis. 2011;204:268\u201373.","journal-title":"J Infect Dis"},{"key":"2566_CR11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(05)67529-0","volume":"366","author":"SK West","year":"2005","unstructured":"West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet. 2005;366:1296\u2013300.","journal-title":"Lancet"},{"issue":"2","key":"2566_CR12","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1371\/journal.pntd.0000376","volume":"3","author":"T Lakew","year":"2009","unstructured":"Lakew T, House J, Hong KC, Yi E, Alemayehu W, Melese M, et al. Reduction and return of infectious trachoma in severely affected communities in Ethiopia. PLoS Negl Trop Dis. 2009;3(2):e376.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"2566_CR13","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1371\/journal.pntd.0000507","volume":"3","author":"T Lakew","year":"2009","unstructured":"Lakew T, Alemayehu W, Melese M, Yi E, House JI, Hong KC, et al. Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution. PLoS Negl Trop Dis. 2009;3(8):e507.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2566_CR14","doi-asserted-by":"crossref","first-page":"e0003610","DOI":"10.1371\/journal.pntd.0003610","volume":"9","author":"V Jiminez","year":"2015","unstructured":"Jiminez V, Gelderblom HC, Mann-Flueckiger R, Emerson PM, Haddad DMDA. For trachoma: how long is not long enough? PLoS Negl Trop Dis. 2015;9(3):e0003610.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9064","key":"2566_CR15","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(97)01355-X","volume":"349","author":"PJ Dolin","year":"1997","unstructured":"Dolin PJ, Faal H, Johnson GJ, Minassian D, Sowa S, Day S, et al. Reduction of trachoma in a sub-Saharan village in the absence of a disease control programme. Lancet. 1997;349(9064):1511\u20132.","journal-title":"Lancet"},{"issue":"2\u20133","key":"2566_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1076\/opep.8.2.145.4169","volume":"8","author":"A Hoeschmann","year":"2001","unstructured":"Hoeschmann A, Metcalfe N, Kanjaloti S, Godia H, Mtambo O, Chipeta T, et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophth Epidemiol. 2001;8(2\u20133):145\u201353.","journal-title":"Ophth Epidemiol"},{"issue":"6","key":"2566_CR17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/342298","volume":"35","author":"H Jha","year":"2002","unstructured":"Jha H, Chaudary J, Bhatta R, Miao Y, Osaki-Holm S, Gaynor B, et al. Disappearance of trachoma in western Nepal. Clinical. Infect Dis. 2002;35(6):765\u20138.","journal-title":"Infect Dis"},{"issue":"10","key":"2566_CR18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.295.10.1142","volume":"295","author":"JD Chidambaram","year":"2006","unstructured":"Chidambaram JD, Alemeyehu W, Melese M, Lakew T, Yi E, House J, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006;295(10):1142\u20136.","journal-title":"JAMA"},{"issue":"5","key":"2566_CR19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3201\/eid0905.020577","volume":"9","author":"BD Gaynor","year":"2003","unstructured":"Gaynor BD, Miao Y, Cevallos V, Jha H, Chaudary JS, Bhatta R, et al. Eliminating trachoma in areas with limited disease. Emerg Infect Dis. 2003;9(5):596\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"2566_CR20","doi-asserted-by":"crossref","first-page":"e2900","DOI":"10.1371\/journal.pntd.0002900","volume":"8","author":"AR Last","year":"2014","unstructured":"Last AR, Burr SE, Weiss HA, Harding-Esch EM, Cassama E, Nabicassa M, et al. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-na\u00efve trachoma-hyperendemic communities of the Bijag\u00f3s archipelago, Guinea Bissau. PLoS Negl Trop Dis. 2014;8(6):e2900.","journal-title":"PLoS Negl Trop Dis"},{"key":"2566_CR21","doi-asserted-by":"crossref","unstructured":"Last AR, Burr SE, Alexander ND, Harding-Esch E, Roberts C, Cassama E, et al. Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study. Pathog Dis. 2017 May 3; [Epub ahead of print]","DOI":"10.1093\/femspd\/ftx050"},{"issue":"7","key":"2566_CR22","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1128\/JCM.00622-13","volume":"51","author":"C Roberts","year":"2013","unstructured":"Roberts C, Last A, Molina-Gonzalez S, Cassama E, Butcher R, Nabicassa M, et al. Development and evaluation of a next generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections. J Clin Microbiol. 2013;51(7):2195\u2013203.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2566_CR23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/JCM.02618-13","volume":"52","author":"A Last","year":"2014","unstructured":"Last A, Roberts CH, Cassama E, Nabicassa M, Molina-Gonzalez S, Burr SE, et al. Plasmid copy number and disease severity in naturally occurring ocular Chlamydia trachomatis infection. J Clin Microbiol. 2014;52(1):324\u20137.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2566_CR24","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1371\/journal.pntd.0000861","volume":"4","author":"E Harding-Esch","year":"2010","unstructured":"Harding-Esch E, Edwards T, Mkocha H, Munoz B, Holland MJ, Burr SE, et al. Trachoma prevalence and associated risk factors in the Gambia and Tanzania: baseline results of a cluster randomized controlled trial. PLoS Negl Trop Dis. 2010;4(11):e861.","journal-title":"PLoS Negl Trop Dis"},{"key":"2566_CR25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-3156.2008.02034.x","volume":"13","author":"T Edwards","year":"2008","unstructured":"Edwards T, Harding-Esch EM, Hailu G, Andreason A, Mabey DC, Todd J, Cumberland P. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin. Tropical Med Int Health. 2008;13:556\u201365.","journal-title":"Tropical Med Int Health"},{"key":"2566_CR26","first-page":"5728","volume":"54","author":"B Munoz","year":"2013","unstructured":"Munoz B, King J, Ngondi J, Emerson P, West S. Estimation of design effect, sample size and number of clusters needed for trachoma prevalence surveys. Invest Ophth Vis Sci. 2013;54:5728.","journal-title":"Invest Ophth Vis Sci"},{"issue":"4","key":"2566_CR27","first-page":"477","volume":"65","author":"B Thylefors","year":"1987","unstructured":"Thylefors B, Dawson CR, Jones BR, West SK, Taylor HRA. Simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477\u201383.","journal-title":"Bull World Health Organ"},{"issue":"9179","key":"2566_CR28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(98)12387-5","volume":"354","author":"J Schachter","year":"1999","unstructured":"Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, et al. Azithromycin and the control of trachoma. Lancet. 1999;354(9179):630\u20135.","journal-title":"Lancet"},{"key":"2566_CR29","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1167\/iovs.03-0107","volume":"44","author":"MJ Burton","year":"2003","unstructured":"Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, Bah M, et al. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci. 2003;44:4215\u201322.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2566_CR30","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1371\/journal.pntd.0000306","volume":"2","author":"AA Andreasen","year":"2008","unstructured":"Andreasen AA, Burton MJ, Holland MJ, Polley S, Faal N, Mabey DC, Bailey RL. Chlamydia trachomatis ompA variants in trachoma: what do they tell us? PLoS Negl Trop Dis. 2008;2(9):e306.","journal-title":"PLoS Negl Trop Dis"},{"key":"2566_CR31","unstructured":"Harding-Esch E, Christerson L, Grannas K, Roberts C, Holland M, Andreasen A, et al. Chlamydial Infections: Proceedings of the twelfth international symposium on human chlamydial infections. In: Schachter J, editor. San Francisco: International Chlamydia Symposium; 2010."},{"issue":"4","key":"2566_CR32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1473-3099(05)70032-3","volume":"5","author":"JD Chidambaram","year":"2005","unstructured":"Chidambaram JD, Lee DC, Porco TC, Lietman TM. Mass antibiotics for trachoma and the Allee effect. Lancet Infect Dis. 2005;5(4):194\u20136.","journal-title":"Lancet Infect Dis"},{"key":"2566_CR33","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(05)61029-X","volume":"365","author":"MJ Burton","year":"2005","unstructured":"Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet. 2005;365:1321\u20138.","journal-title":"Lancet"},{"issue":"7","key":"2566_CR34","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1167\/iovs.14-14148","volume":"55","author":"J Yohannan","year":"2014","unstructured":"Yohannan J, He B, Wang J, Greene G, Schein Y, Mkocha H, et al. Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment. Invest Ophthalmol Vis Sci. 2014;55(7):4144\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2566_CR35","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/514151","volume":"176","author":"LD Bobo","year":"1997","unstructured":"Bobo LD, Novak N, Munoz B, Hsieh YH, Quinn TC, West S. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis. 1997;176(6):1524\u201330.","journal-title":"J Infect Dis"},{"issue":"4","key":"2566_CR36","doi-asserted-by":"crossref","first-page":"e2761","DOI":"10.1371\/journal.pntd.0002761","volume":"8","author":"JS Lee","year":"2014","unstructured":"Lee JS, Munoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children. PLoS Negl Trop Dis. 2014;8(4):e2761.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"2566_CR37","doi-asserted-by":"crossref","first-page":"e0005080","DOI":"10.1371\/journal.pntd.0005080","volume":"10","author":"AM Ramadhani","year":"2016","unstructured":"Ramadhani AM, Derrick T, Macleod D, Holland MJ, Burton MJ. The relationship between active trachoma and ocular Chlamydia trachomatis infection before and after mass antibiotic treatment. PLoS Negl Trop Dis. 2016;10(10):e0005080.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2566_CR38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/dna.2011.1333","volume":"31","author":"P Srivastava","year":"2012","unstructured":"Srivastava P, Bhengraj AR, Jha HC, Vardhan H, Jha R, Singh LC, et al. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women. DNA Cell Biol. 2012;31(3):392\u2013401.","journal-title":"DNA Cell Biol"},{"issue":"8","key":"2566_CR39","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1371\/journal.pmed.0030266","volume":"3","author":"N Faal","year":"2006","unstructured":"Faal N, Bailey RL, Jeffries D, Joof H, Sarr I, Laye M, et al. Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? PLoS Med. 2006;3(8):e266.","journal-title":"PLoS Med"},{"issue":"1","key":"2566_CR40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12916-016-0614-6","volume":"14","author":"A Pinsent","year":"2016","unstructured":"Pinsent A, Burton MJ, Gambhir MJ. Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study. BMC Med. 2016;14(1):71.","journal-title":"BMC Med"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-017-2566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T20:43:29Z","timestamp":1514407409000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-017-2566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2566"],"URL":"https:\/\/doi.org\/10.1186\/s13071-017-2566-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"624"}}